Prognostic factors in patients with pathological and N2 non-small cell lung cancer

Annals of Thoracic and Cardiovascular Surgery

Volumn 14, Issue 1, 2008, Pages 1-2

  Saito, Makoto ^a   Kato, Harubumi ^b  

^a Ibaraki pref   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; DIAGNOSTIC IMAGING; EDITORIAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE;

CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSTIC IMAGING; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 43249119920     PISSN: 13411098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (12)

1. Pearson FG, DeLarue NC, Ilves R, Todd TR, Cooper JD. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with respectable cancer of the lung. J Thorac Cardiovasc Surg 1982; 83: 1-11.
2. Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg Clin North Am 1987; 67: 1037-49.
3. Watanabe Y, Shimizu J, Oda M, Hayashi Y, Watanabe S, et al. Aggressive surgical intervention in N2 nonsmall cell cancer of the lung. Ann Thorac Surg 1991; 51: 253-61.
4. Vansteenkiste JF, De Leyn PR, Deneffe GJ, Stalpaert G, Nackaerts KL, et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Ann Thorac Surg 1997; 63: 1441-50.
5. Davtyan HG, Corno AF, Laks H, Bhuta S, Flynn WM, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96: 44-7.
6. Goldstraw P, Mannam GC, Kaplan DK, Michail P. Surgical management of non-small cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg 1994; 107: 19-28.
7. Asamura H, Nakayama H, Kondo H, Tsuchiya R, Naruke T. Lobe-specific extent of systemic lymphnode dissection for non-small cell lung carcinomas according to a retrospective study of metastatis and prognosis. J Thorac Cardiovasc Surg 1999; 117: 1102-11.
8. Mountain CF. Surgery for stage IIIa-N2 non-small cell lung cancer. Cancer 1994; 73: 2589-98.
9. Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, et al. The prognosis of surgically resected N2 nonsmall cell lung cancer: the importance of clinical N status. J Thorac Cardiovasc Surg 1999; 118: 145-53.
10. Kim KJ, Ahn YC, Lim do H, Han J, Park K, et al. Analyses on prognostic factors following tri-modality therapy for stage IIIa non-small call lung cancer. Lung Cancer 2007; 55: 329-36.
11. Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 1996; 111: 642-8.
12. Chin R Jr, Ward R, Keyes JW, Choplin RH, Reed JC, et al. Mediastinal staging of non-small cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995; 152: 2090-6.